Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease narcolepsy
Symptom C0007384|cataplexy
Sentences 170
PubMedID- 24142146 The pathogenesis of sporadic narcolepsy with cataplexy is likely autoimmune with hypocretin neurons being a target (kornum et al., 2011a), and possibly interacting with other neurotransmission systems during development (sundvik et al., 2011).
PubMedID- 22259780 The patients were categorized according to the international classification of sleep disorders (icsd)-2 into 2 groups: (1) narcolepsy with cataplexy and (2) narcolepsy without cataplexy but with a mean sleep latency of less than or equal to 8 min and the presence of 2 or more sleep-onset rem periods (soremps) during the mslt.
PubMedID- 21931493 It is thought that narcolepsy with cataplexy is secondary to loss of hypothalamic hypocretin neurons in those genetically predisposed to the disorder by possession of human leukocyte antigen dqb1*0602. the diagnostic criteria for narcolepsy are based on symptoms, laboratory sleep tests, and serum levels of hypocretin.
PubMedID- 20337187 Study objectives: narcolepsy with cataplexy is caused by a loss of orexin (hypocretin) signaling, but the physiologic mechanisms that result in poor maintenance of wakefulness and fragmented sleep remain unknown.
PubMedID- 23622291 It can be secondary to brain tumors or several rare diseases, but in most cases narcolepsy with or without cataplexy is a primary condition, better explained by the selective loss of hypocretin neurons in posterolateral hypothalamus.
PubMedID- 25325489 Study objectives: we investigated the diagnostic accuracy of a nocturnal sleep onset rapid eye movement sleep period (nsoremp) for the identification of narcolepsy with cataplexy (n+c) among children and adolescents referred to the sleep laboratory for an overnight polysomnography (psg) and multiple sleep latency test (mslt).
PubMedID- 21930661 The mean ± sd age of symptom onset was 9.3 ± 3.0 years; yearly narcolepsy with cataplexy onset ranged from one to three during the period from 1998 to 2006, from six to nine in the period from 2007 to 2009 and a single patient in 2010. diagnostic delay was 1.8 ± 2.1 years (range 3 weeks–9 years).
PubMedID- 23288981 Study objectives: although hypothesized through animal studies, a temporal and causal association between hypocretin deficiency and the onset of narcolepsy with cataplexy (nc) has never been proven in humans.
PubMedID- 26313387 narcolepsy with cataplexy and parkinson's disease.
PubMedID- 19732319 In this population-based case-control study, we sought to identify all prevalent cases of narcolepsy with cataplexy aged 18-50 years as of 1 july 2001, in king county, washington.
PubMedID- 23946711 Results: a total of 100 consecutive narcolepsy patients (87 with cataplexy nc, 13 without cataplexy n) were included in the analysis.
PubMedID- 24312261 These findings suggest that symptomatic differences between narcolepsy with and without cataplexy are related to either the severity and localizations of hypocretin neurons loss or a different pathway.
PubMedID- 24780136 The international classification of sleep disorders, second edition (icsd-2) criteria, were used to classify sleep disorders (e.g., delayed sleep phase disorder, hypersomnia, narcolepsy with cataplexy nc, restless legs syndrome rls, periodic limb movement disorder plmd, insomnia, rapid eye movement sleep behavior disorder rbd, and obstructive sleep apnea osa).
PubMedID- 22406785 Mean age at onset of symptoms was 25+/-10 years; 12 (60%) patients had narcolepsy with cataplexy, 4 (20%) patients presented with all cardinal symptoms of narcolepsy, 8 (40%) with 3 symptoms, while 8 (40%) presented with 2 symptoms.
PubMedID- 23219054 narcolepsy without cataplexy is a condition rarely associated with hypocretin deficiency.
PubMedID- 21677900 However, subjects in the narcolepsy with cataplexy group had significantly higher scores on the eysenck impulsiveness scale (p < 0.05), with 10.0% categorized as impulsive, compared to 6.7% of the narcolepsy without cataplexy group and none of the controls.
PubMedID- 23228163 Our results demonstrate that narcolepsy with cataplexy accurately perceives and discriminates facial emotions, and regulates emotions normally.
PubMedID- 25098533 Objective: conflicting data have been reported on resting autonomic tone in narcolepsy with cataplexy (nc), including reduced or increased sympathetic activity; to settle this important point, we aimed to measure the resting sympathetic and cardiovascular activities in patients with nc by direct microneurographic monitoring of muscle sympathetic nerve activity (msna) during wakefulness.
PubMedID- 19955018 Methods: seven narcolepsy with cataplexy patients underwent daytime videopolygraphy using humorous movies or/and jokes to trigger cataplectic attacks.
PubMedID- 25707395 Finally, our classifiers could be used to identify the risk haplotypes for japanese narcolepsy with cataplexy, hla-drb1*15:01 and hla-dqb1*06:02, with 100% and 99.7% accuracy, respectively; therefore, these classifiers can be used to supplement the current lack of hla genotyping data in widely available genome-wide association study data sets.
PubMedID- 24169281 Methods: a total of 139 narcoleptic patients, including 111 narcolepsy with typical cataplexy (nc) and 28 narcolepsy without cataplexy (nwc), were diagnosed at the sleep centre of peking university people's hospital from april 2003 to march 2012.
PubMedID- 21484510 Purpose: this study aims to report on catathrenia occurring in narcolepsy with cataplexy (nc) patients under sodium oxybate (so) treatment.
PubMedID- 24727570 Remarkably, narcolepsy with or without cataplexy with low/intermediate or normal cerebrospinal fluid hypocretin-1 is present in both diseases.
PubMedID- 23853567 Status cataplecticus is a rare manifestation of narcolepsy with cataplexy episodes recurring for hours or days, without a refractory period, in the absence of emotional triggers.
PubMedID- 24694762 In humans, narcolepsy with cataplexy (narcolepsy) is a sleep disorder that is characterized by sleepiness, cataplexy and rapid eye movement (rem) sleep abnormalities.
PubMedID- 23950869 narcolepsy with cataplexy is characterised by an excessive daytime sleepiness, cataplexy and disturbed nocturnal sleep.
PubMedID- 23734110 Major advances in the past decade have led a better understanding of the pathophysiology of narcolepsy with cataplexy (nc) caused by the early loss of hypothalamic hypocretin neurons.
PubMedID- 22468916 Models for narcolepsy with cataplexy drug discovery.
PubMedID- 20854137 narcolepsy with cataplexy (nc) is a sleep disorder caused by the loss of the hypothalamic neurons producing hypocretin.
PubMedID- 26518595 Design: hla class i (a, b, and c) and ii (dqb1) genotypes were analyzed in 944 european narcolepsy with cataplexy patients and in 4043 control subjects matched by country of origin.
PubMedID- 22783726 The objective of this study was to perform global gene expression profiling of patients affected by narcolepsy with cataplexy (nrlcp).
PubMedID- 25784528 The cerebrospinal fluid level of orexin/hypocretin was low (92 ng/l), leading to a diagnosis of narcolepsy with cataplexy according to the international classification of sleep disorders (icsd)-2 criteria.
PubMedID- 22167152 Objective: based on the clinical observation that patients suffering from narcolepsy with cataplexy (nc) have cataplectic attacks when they experience positive emotions, it is therefore hypothesised that the abnormal processing of external emotional input through the limbic system, or motor dysregulation induced by emotions, takes place during these episodes.
PubMedID- 25165990 Hypocretin deficiency appears to underlie narcolepsy with cataplexy, and infections and vaccinations have been associated with disease onset.
PubMedID- 21148631 Patients or participants: eight male hypocretin-deficient narcolepsy with cataplexy patients and eight controls matched for sex, age, body mass index, waist-to-hip ratio and fat percentage were enrolled.
PubMedID- 22768053 The latter choice may be considered as particularly difficult as narcolepsy with cataplexy is an orphan disease associated with several comorbid conditions such as obesity.
PubMedID- 25576137 narcolepsy with and without cataplexy, idiopathic hypersomnia with and without long sleep time: a cluster analysis.
PubMedID- 22547897 We retrospectively evaluated 27 children ranging from 6 to 16 years old, suffering from narcolepsy with cataplexy, who had been treated with off-label sodium oxybate and had been followed in a clinical setting.
PubMedID- 21173745 Background: narcolepsy with cataplexy (nc) differs from narcolepsy without cataplexy (nwoc) in the cerebrospinal fluid levels of hypocretin.
PubMedID- 22467990 Study objective: narcolepsy with cataplexy (nc) is associated with loss of hypocretin neurons in the lateral hypothalamus involved in the circadian timing of sleep and wakefulness, and many biologic functions including autonomic control.
PubMedID- 21347440 The hypocretin/orexin (hcrt/orx) neurons of the hypothalamus play an important role in maintaining arousal, since their absence results in narcolepsy with cataplexy (for reviews, see ).
PubMedID- 21723190 Objectives: to compare differences in nocturnal and daytime polysomnographic findings between narcolepsy (na) with and without cataplexy (ca) and idiopathic hypersomnia without long sleep time (ihs w/o lst).
PubMedID- 20967199 In humans, narcolepsy with cataplexy (nc) is characterised by selective loss of hypocretin neurons in the brain with low levels of hypocretin in the cerebro-spinal fluid (csf) , 7.
PubMedID- 21463040 Objective: narcolepsy with cataplexy (nc) affects neurotransmitter systems regulating emotions and cognitive functions.
PubMedID- 20129934 We hypothesized that rapid eye movement sleep behaviour disorder coexists with cataplexy in narcolepsy due to hypocretin deficiency.
PubMedID- 26074743 However, because there are also legitimate medical uses for ghb, such for cataplexy attacks in patients with narcolepsy, in the form of sodium oxybate ghb was placed in schedule iii as xyrem®.
PubMedID- 24368893 In humans, orexin deficiency leads to narcolepsy with cataplexy (nishino et al., 2000).
PubMedID- 25264897 Main outcome measures: confirmed narcolepsy with or without cataplexy with onset of excessive daytime sleepiness between january 1st, 2009, and december 31st, 2010.
PubMedID- 26483903 narcolepsy with cataplexy after a/h1n1 vaccination - a case reported from cuba.
PubMedID- 23689193 Background: disturbed sleep is a core feature of narcolepsy with cataplexy (nc).

Page: 1 2 3 4